Cargando…

End-stage kidney disease in patients with clinically manifest vascular disease; incidence and risk factors: results from the UCC-SMART cohort study

BACKGROUND: Patients with cardiovascular disease (CVD) are at increased risk of end-stage kidney disease (ESKD). Insights into the incidence and role of modifiable risk factors for end-stage kidney disease may provide means for prevention in patients with cardiovascular disease. METHODS: We included...

Descripción completa

Detalles Bibliográficos
Autores principales:	Østergaard, Helena Bleken, Westerink, Jan, Verhaar, Marianne C., Bots, Michiel L., Asselbergs, Folkert W., de Borst, Gert J., Kappelle, L. Jaap, Visseren, Frank L. J., van der Leeuw, Joep
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8494654/ https://www.ncbi.nlm.nih.gov/pubmed/33713332 http://dx.doi.org/10.1007/s40620-021-00996-1

Ejemplares similares

Lifestyle changes and kidney function: A 10‐year follow‐up study in patients with manifest cardiovascular disease
por: Østergaard, Helena Bleken, et al.
Publicado: (2022)

Relationship between classic vascular risk factors and cumulative recurrent cardiovascular event burden in patients with clinically manifest vascular disease: results from the UCC-SMART prospective cohort study
por: de Vries, Tamar Irene, et al.
Publicado: (2021)

Cohort profile: the Utrecht Cardiovascular Cohort–Second Manifestations of Arterial Disease (UCC-SMART) Study–an ongoing prospective cohort study of patients at high cardiovascular risk in the Netherlands
por: Castelijns, Maria C, et al.
Publicado: (2023)

Risk Factor Clusters and Cardiovascular Disease in High-Risk Patients: The UCC-SMART Study
por: Holthuis, Emily I., et al.
Publicado: (2021)

Comment on Vistisen et al. A Validated Prediction Model for End-Stage Kidney Disease in Type 1 Diabetes. Diabetes Care 2021;44:901–907
por: Østergaard, Helena Bleken, et al.
Publicado: (2021)

The influence of baseline risk on the relation between HbA1c and risk for new cardiovascular events and mortality in patients with type 2 diabetes and symptomatic cardiovascular disease
por: Bots, Sophie H., et al.
Publicado: (2016)

Physical Activity and Characteristics of the Carotid Artery Wall in High‐Risk Patients—The SMART (Second Manifestations of Arterial Disease) Study
por: Boss, H. Myrthe, et al.
Publicado: (2017)

External applicability of SGLT2 inhibitor cardiovascular outcome trials to patients with type 2 diabetes and cardiovascular disease
por: Smidt, Lisanne C. A., et al.
Publicado: (2021)

Extracellular vesicle protein levels are related to brain atrophy and cerebral white matter lesions in patients with manifest vascular disease: the SMART-MR study
por: Kanhai, Danny A, et al.
Publicado: (2014)

One Heartbeat Away from a Prediction Model for Cardiovascular Diseases in Patients with Chronic Kidney Disease: A Systematic Review
por: Smit, Leanne C.M., et al.
Publicado: (2023)

Cardiovascular risk and lifetime benefit from preventive treatment in type 2 diabetes: A post hoc analysis of the CAPTURE study
por: Østergaard, Helena Bleken, et al.
Publicado: (2022)

Estimated Life Expectancy Without Recurrent Cardiovascular Events in Patients With Vascular Disease: The SMART‐REACH Model
por: Kaasenbrood, Lotte, et al.
Publicado: (2018)

The effect of computerized decision support systems on cardiovascular risk factors: a systematic review and meta-analysis
por: Groenhof, T. Katrien J., et al.
Publicado: (2019)

Platelet aggregation inhibitor prescription for newly diagnosed peripheral arterial disease in the Netherlands: a cohort study
por: Brand, Aarent RT, et al.
Publicado: (2021)

Screen-detected abnormal ankle brachial index: A risk indicator for future cardiovascular morbidity and mortality in patients with manifest cardiovascular disease
por: Jagt, Vivianne L., et al.
Publicado: (2022)

Added value of cardiovascular calcifications for prediction of recurrent cardiovascular events and cardiovascular interventions in patients with established cardiovascular disease
por: van ’t Klooster, Cilie C., et al.
Publicado: (2021)

Chronic kidney disease and atrial fibrillation: A dangerous combination
por: Ocak, Gurbey, et al.
Publicado: (2022)

The relation between urinary sodium and potassium excretion and risk of cardiovascular events and mortality in patients with cardiovascular disease
por: Groenland, Eline H., et al.
Publicado: (2022)

The relation between systemic inflammation and incident cancer in patients with stable cardiovascular disease: a cohort study
por: van’t Klooster, Cilie C, et al.
Publicado: (2019)

Prediction of Lifetime and 10-Year Risk of Cancer in Individual Patients With Established Cardiovascular Disease
por: van ’t Klooster, Cilie C., et al.
Publicado: (2020)

Cisco Unified Contact Center Enterprise (UCCE)
por: Ford, Gary
Publicado: (2012)

Rs964184 (APOA5-A4-C3-A1) Is Related to Elevated Plasma Triglyceride Levels, but Not to an Increased Risk for Vascular Events in Patients with Clinically Manifest Vascular Disease
por: van de Woestijne, Anton P., et al.
Publicado: (2014)

Arterial stiffness as a risk factor for cardiovascular events and all‐cause mortality in people with Type 2 diabetes
por: Sharif, S., et al.
Publicado: (2019)

Thyroid-stimulating hormone levels in the normal range and incident type 2 diabetes mellitus
por: de Vries, T. I., et al.
Publicado: (2018)

Ribose utilization by the human commensal Bifidobacterium breve UCC2003
por: Pokusaeva, Karina, et al.
Publicado: (2010)

The essential genomic landscape of the commensal Bifidobacterium breve UCC2003
por: Ruiz, Lorena, et al.
Publicado: (2017)

Evaluating a cardiovascular disease risk management care continuum within a learning healthcare system: a prospective cohort study
por: Groenhof, T Katrien J, et al.
Publicado: (2020)

Development of a clinical decision tool to reduce diagnostic testing for primary aldosteronism in patients with difficult-to-control hypertension
por: van Kleef, Monique E. A. M., et al.
Publicado: (2020)

Applicability of Transcutaneous Oxygen Tension Measurement in the Assessment of Chronic Limb-Threatening Ischemia
por: Leenstra, Bernard, et al.
Publicado: (2019)

Ischemic stroke recurrence and mortality in different imaging phenotypes of ischemic cerebrovascular disease: The SMART-MR Study
por: Lucci, Carlo, et al.
Publicado: (2023)

Routinely measured hematological parameters and prediction of recurrent vascular events in patients with clinically manifest vascular disease
por: Kofink, Daniel, et al.
Publicado: (2018)

Optimizing cardiovascular risk assessment and registration in a developing cardiovascular learning health care system: Women benefit most
por: Groenhof, T. Katrien J., et al.
Publicado: (2023)

Use of a Diagnostic Score to Prioritize Computed Tomographic (CT) Imaging for Patients Suspected of Ischemic Stroke Who May Benefit from Thrombolytic Therapy
por: Hwong, Wen Yea, et al.
Publicado: (2016)

Low-Density Lipoprotein Cholesterol Target Attainment in Patients With Established Cardiovascular Disease: Analysis of Routine Care Data
por: Groenhof, T Katrien J, et al.
Publicado: (2020)

Insulin resistance increases the occurrence of new cardiovascular events in patients with manifest arterial disease without known diabetes. The SMART study
por: Verhagen, Sandra N, et al.
Publicado: (2011)

Sentimiento de inseguridad urbana en jóvenes bachilleres de la UCC
por: García López, Valeria
Publicado: (2010)

Carbohydrate Syntrophy enhances the establishment of Bifidobacterium breve UCC2003 in the neonatal gut
por: O’Connell Motherway, Mary, et al.
Publicado: (2018)

Cardiovascular risk factor treatment targets and renal complications in high risk vascular patients: a cohort study
por: Selvarajah, Sharmini, et al.
Publicado: (2011)

Prevalence and clinical characteristics of apparent therapy-resistant hypertension in patients with cardiovascular disease: a cross-sectional cohort study in secondary care
por: de Beus, Esther, et al.
Publicado: (2017)

Use of Antihypertensive Drugs and Ischemic Stroke Severity – Is There a Role for Angiotensin-II?
por: Hwong, Wen Yea, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_3roqp1de90jtkvh1nqhsba8n1g